Neural Therapeutics Inc. (NURL)
Neural Therapeutics Inc. is a diversified issuer with ~13.4% warrant dilution, 1 recent financing, and recent insider activity.
- Warrant series
- 2
- Recent financings
- 1
- Ticker
- NURL
- Exchange
- CSE
- Primary commodity
- diversified
- Sector
- mining
- Shares outstanding
- 169,200,537 As of 2026-06-22
Price chart
Trader’s cheat sheet
Loading cheat sheet…
Warrant overhang
2 active warrant series covering 22,640,613 shares (~13.4% potential dilution); nearest expiry 2027-03-07.
View warrant overhang tool →Dilution-true chart
Price history with the company's active warrant supply walls (amber) and free-trading unlock dates (violet) overlaid. Levels and dates are Pacific Time.
Recent financings
- othersource →
Latest insider transaction
1,381,426 shares ($138,143) on 2025-03-07.
View insider activity →Recent news
Latest coverage: 41 days ago
- Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reportingquotemedia_newsfile · 2026-06-19
- Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Marketquotemedia_newsfile · 2026-06-12
- Canadian Companies Moving the Markets, Evening edition <br>Fri, May 22, 2026 as of 4:00 pm ETquotemedia_qm_canadian_market_movers · 2026-05-22
Community
User-generated discussion. Not investment advice — verify claims against source filings.
Sign in to post in the $NURL room.
Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at reference prices (live spot feed temporarily unavailable). This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.